RELAPSE LEUKEMIA
Clinical trials for RELAPSE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested in fight against Tough-to-Treat leukemias
Disease control Recruiting nowThis study is testing whether combining two new drugs, revumenib and mezigdomide, is a safe and effective treatment for people with specific types of acute leukemia that have come back or not responded to prior therapy. It will involve about 52 participants aged 12 and older who …
Matched conditions: RELAPSE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists hunt genetic clues to make leukemia treatment safer for kids
Knowledge-focused Recruiting nowThis study aims to understand how a child's genes might influence their risk of severe side effects and how well they respond to standard leukemia treatment. Researchers will observe about 550 Indian children with acute lymphoblastic leukemia (ALL) to find genetic markers linked …
Matched conditions: RELAPSE LEUKEMIA
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC